Brain scans probe Serotonin's role in Parkinson's pain

NCT ID NCT06008704

Recruiting now Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to understand why some people with Parkinson's disease experience central pain. Researchers will use brain scans (PET and MRI) to examine the serotonin system in 34 participants. The goal is to see how serotonin relates to pain, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal why some Parkinson's patients experience central pain, pointing toward future pain management strategies.
What could go wrong: This is a small, early-stage observational study (34 participants) focused on understanding, not treatment. It may not lead to any direct therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Locations

Centre Hospitalier Universitaire de Toulouse
RECRUITING

Toulouse, Haute-Garonne, 31000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.